세계의 위풍선 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Intragastric Balloon Market is presumed to reach the market size of nearly USD 160.52 Million by 2032 from USD 57.84 Million in 2023 with a CAGR of 12.01% under the study period 2024-2032.

Intragastric balloon is basically a modern weight-loss procedure and one of the endoscopic treatment indicated for obesity. In this procedure, a saline-filled balloon is placed in individuals stomach, that helps in reducing weight by limiting how much an individual can eat. It also makes user feel full faster. This procedure for patients who cannot lose weight by any other means and are prone to serious health problems related to obesity.

MARKET DYNAMICS

Rising obesity epidemic worldwide, which effect more than 600 million people globally. According to WHO, approx. 65% of the world population live in countries where being overweight and obese kills more people than being under weight. These factor is propel the market growth. The other factors that propel the market growth are technological advancement in weight loss management and devices coupled with reduced cost associated with treatment. However, risks of acute pancreatitis and overinflation associated with intragastric balloon hampers the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Intragastric Balloon. The growth and trends of Intragastric Balloon industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Intragastric Balloon market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Administration

• Pill Form
• Endoscopy

By Type

• Single
• Dual
• Triple

By Material

• Saline Filled
• Gas Filled

By End-use

• Hospitals
• Clinics
• Ambulatory Surgical Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intragastric Balloon market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Intragastric Balloon market include Apollo Endosurgery Inc., Obalon Therapeutics Inc., Allurion Technologies Inc., Spatz3, Helioscopie, Endalis, MEDSIL, ReShape Medical Inc., Lexel Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. INTRAGASTRIC BALLOON - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Administration
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By Material
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAGASTRIC BALLOON MARKET ANALYSIS BY ADMINISTRATION

• 5.1. Overview By Administration
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Administration
• 5.4. Pill Form Historic and Forecast Sales By Regions
• 5.5. Endoscopy Historic and Forecast Sales By Regions

6. GLOBAL INTRAGASTRIC BALLOON MARKET ANALYSIS BY TYPE

• 6.1. Overview By Type
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Type
• 6.4. Single Historic and Forecast Sales By Regions
• 6.5. Dual Historic and Forecast Sales By Regions
• 6.6. Triple Historic and Forecast Sales By Regions

7. GLOBAL INTRAGASTRIC BALLOON MARKET ANALYSIS BY MATERIAL

• 7.1. Overview By Material
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Material
• 7.4. Saline Filled Historic and Forecast Sales By Regions
• 7.5. Gas Filled Historic and Forecast Sales By Regions

8. GLOBAL INTRAGASTRIC BALLOON MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-use
• 8.2. Historical and Forecast Data
• 8.3. Analysis By End-use
• 8.4. Hospitals Historic and Forecast Sales By Regions
• 8.5. Clinics Historic and Forecast Sales By Regions
• 8.6. Ambulatory Surgical Centers Historic and Forecast Sales By Regions

9. GLOBAL INTRAGASTRIC BALLOON MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE INTRAGASTRIC BALLOON COMPANIES

• 10.1. Intragastric Balloon Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF INTRAGASTRIC BALLOON INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Apollo Endosurgery Inc.
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Obalon Therapeutics Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Allurion Technologies Inc.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Spatz3
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Helioscopie
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Endalis
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. MEDSIL
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. ReShape Medical Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Lexel Medical
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies